1036 / 1851
757 oligometastatic patients
Training and validation cohorts
Surgery to primary tumors: 83.9%
Surgery to metastatic patients: 62.3%
Ashworth A et al, Clin Lung Cancer 2014;15
RPA OVERALL SURVIVAL
47.8%
13.8%
|
|
1036 / 1851
757 oligometastatic patients
Training and validation cohorts
Surgery to primary tumors: 83.9%
Surgery to metastatic patients: 62.3%
Ashworth A et al, Clin Lung Cancer 2014;15
RPA OVERALL SURVIVAL
47.8%
13.8%